Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Preferred Dividend Payments: 2011-2012

Historic Preferred Dividend Payments for Cytokinetics (CYTK) over the last 2 years, with Dec 2012 value amounting to $1.3 million.

  • Cytokinetics' Preferred Dividend Payments was N/A to $4.2 million in Q3 2013 from the same period last year, while for Sep 2013 it was $12.5 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2012, which is 54.25% down from last year.
  • Per Cytokinetics' latest filing, its Preferred Dividend Payments stood at $1.3 million for FY2012, which was down 54.25% from $2.9 million recorded in FY2011.
  • Cytokinetics' 5-year Preferred Dividend Payments high stood at $2.9 million for FY2011, and its period low was $1.3 million during FY2012.
  • In the last 2 years, Cytokinetics' Preferred Dividend Payments had a median value of $2.1 million in 2011 and averaged $2.1 million.
  • Data for Cytokinetics' Preferred Dividend Payments shows a maximum YoY plummeted of 54.25% (in 2012) over the last 5 years.
  • Over the past 2 years, Cytokinetics' Preferred Dividend Payments (Yearly) stood at $2.9 million in 2011, then tumbled by 54.25% to $1.3 million in 2012.